Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02638935 · ClinicalTrials.gov registry record · NA
Evaluation of Virtual Touch Tissue Imaging Quantification (VTIQ - 2D-SWE) in the Assessment of BI-RADS® 3 and 4 Lesions
A NA study, sponsored by Heidelberg University.
- Completed
- Registry status
- NA
- Development phase
- 1,304
- Enrollment target
NCT02638935 is a NA study that has completed, run by Heidelberg University. The registered enrollment target is 1,304 participants.
The verdict
NCT02638935, a NA study, has completed, sponsored by Heidelberg University.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,304 participants
- Enrollment target
Study Summary
The primary aim of this study is to evaluate if VTIQ in addition to BI-RADS® categorization can improve the diagnostic accuracy with respect to detection of malignancies, in particular for BI-RADS® categories 3 and 4a. The idea of the study is to restage all patients in categories 3 and 4a according to a predefined VTIQ cut-off value of ≥ 3.5 m/s (37 kPa).
Interventions
- DEVICE Ultrasound- Virtual Touch Tissue Imaging Quantification
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,304 participants |
| Start Date | 2016-02 |
| Est. Completion | 2019-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02638935
The ClinicalTrials.gov registry entry for NCT02638935 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,304 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Heidelberg University, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ultrasound- Virtual Touch Tissue Imaging Quantification is the first listed.
NCT02638935 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02638935 about?
NCT02638935 is a clinical study titled "Evaluation of Virtual Touch Tissue Imaging Quantification (VTIQ - 2D-SWE) in the Assessment of BI-RADS® 3 and 4 Lesions". The primary aim of this study is to evaluate if VTIQ in addition to BI-RADS® categorization can improve the diagnostic accuracy with respect to detection of malignancies, in particular for BI-RADS® categories 3 and 4a. The idea of the study is to restage all patients in categories 3 and 4a according...
What is the current status of trial NCT02638935?
This trial is currently completed. It is a NA study. The enrollment target is 1,304 participants. The study started on 2016-02. Estimated completion is 2019-03.
What interventions are being tested in trial NCT02638935?
The interventions under investigation include: Ultrasound- Virtual Touch Tissue Imaging Quantification (DEVICE).
Who is sponsoring clinical trial NCT02638935?
This trial is sponsored by Heidelberg University, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.